黃奇英

Chi-Ying F. Huang・藥物科學院・生物藥學研究所、分子醫學博士學位學程、醫學生物技術暨檢驗學系、生技醫療經營管理碩士在職學位學程

碩士平均畢業時長
2.13 年
中位數 2.04 年・56 人
在職專班平均畢業時長
2.29 年
中位數 2.03 年・5 人
博士平均畢業時長
6.68 年
中位數 6.06 年・17 人
收錄論文
81 篇
100–114 學年度
全校中位數(供對照)
碩士 2.10・在職專班 2.08・博士 6.11 年

畢業時長趨勢

每學年度畢業人數

只計入有論文收錄的畢業生;中途休學或更換指導教授的學生不會出現在這裡。

研究關鍵字

細胞外囊泡Extracellular vesicles肝癌非小細胞肺癌癌症幹細胞Hepatocellular carcinomaColorectal cancerdrug repurposingOsteoarthritisConnectivity Mapcancer stem cell內質網壓力阿茲海默症Alzheimer's disease間質幹細胞抗藥性drug resistance精準醫療precision medicinelung cancerCancer stem cellsnon-small cell lung cancerNone老藥新用肺癌Extracellular vesicles (EVs)骨關節炎軟骨再生ChondrogenesisCartilage regeneration胞外體大腸直腸癌中草藥再生醫學bioinformaticsMesenchymal stem cellsTP53阿茲海默氏症Alzheimer’s diseasemicroglia細胞凋亡NSCLCThioridazinemicroarray石蓮花吩噻嗪PhenothiazineautophagyPlant-derived nanovesiclesGATA6

想看最新的研究方向與計畫經費,也可以查政府研究計畫(GRB)。

指導論文

學年度論文學制入學提交日期畢業時長
114
Deep learning approaches for deciphering the therapeutic targets of small compounds
生物藥學研究所・共同指導:張牧新
藥物再定位、反向分子對接、AlphaFold、標的優先排序、癌症、drug repurposing、reverse docking、target prioritization、cancer
碩士1132026-07-312.00 年
114
CatiPep-Primed Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Inflammatory and Pain-Associated Mediators in an In Vitro Osteoarthritis Model
生物藥學研究所・共同指導:廖秀蓉
骨關節炎(OA)、疼痛、胜肽預處理之間質幹細胞、細胞外囊泡(EV)、Osteoarthritis (OA)、Pain、Extracellular vesicles (EVs)、Peptide-primed EVs
碩士1132026-07-301.99 年
114
AI-Guided Peptide and Extracellular Vesicle-Based Strategies for Stimulating Chondrogenesis in Osteoarthritis Therapy
生物藥學研究所・共同指導:江季霖、廖秀蓉
骨關節炎、細胞外囊泡、軟骨生成、細胞通訊網路因子 2 (CCN2)、載脂蛋白E基因 (APOE)、軟骨再生、Osteoarthritis、Extracellular vesicles、Chondrogenesis、CCN2、APOE、Cartilage regeneration
碩士1132026-07-301.99 年
114
Therapeutic Applications of Extracellular Vesicles in Age-Related Neurodegenerative Disorder
生物藥學研究所
神經退化性疾病、胞外體、植物奈米囊泡、神經發炎、細胞衰老、Neurodegenerative disease、Extracellular vesicles、Plant-derived nanovesicles、Neuroinflammation、Cellular senescence.
碩士1132026-07-281.99 年
114
Engineered extracellular vesicles for POMGnT1 mRNA delivery and plant-derived nanovesicles for oxidative stress in retina cells
生物藥學研究所
色素性視網膜失養症、細胞奈米通道電穿孔、間質幹細胞外囊泡、植物來源奈米囊泡、Retinitis pigmentosa、Mesenchymal Stem Cell-derived extracellular vesicles、plant-derived nanovesicles
碩士1132026-07-281.99 年
114
Potential Therapeutic Agent to Overcome Drug Resistance in Colorectal Cancer Stem-Like Cells
生物藥學研究所・共同指導:張牧新
大腸直腸癌、癌症幹樣細胞、Drug D、內質網壓力、Notch、GATA6、Colorectal cancer、Cancer stem-like cell、ER stress
碩士1132026-07-271.98 年
114
Exploring the Therapeutic Potential of Engineered Extracellular Vesicles for Immune Modulation in Small Cell Lung Cancer and Fabry Disease
生物藥學研究所・共同指導:江季霖
小細胞肺癌、塔拉妥、惡性胸水、法布瑞氏症、巨噬細胞、器官靶向胜肽、工程化細胞外囊泡、Small Cell Lung Cancer (SCLC)、Tarlatamab、malignant pleural effusion (MPE)、Fabry disease、macrophage、organ targeting peptide、engineered extracellular vesicle (EV)
碩士1132026-07-211.97 年
114
Big Data-Driven Analysis of Dietary Supplements: Mechanistic Insights and Translational Potential for Treating Metabolic Syndrome and Neurodegeneration-Related Diseases
分子醫學博士學位學程
AI–Omics平台、輔助治療策略、膳食補充劑、第二型糖尿病、阿茲海默症、轉譯醫學、生物標誌物導向治療、AI–Omics Platform、Add-on therapeutic strategy、Dietary Supplements、Type 2 diabetes、Alzheimer's disease、Translational medicine、Biomarker-guided therapy
博士1092026-01-295.49 年
114
Bioinformatics Analysis of Rejuvenation-Associated Gene Signatures from Herbal Medicines and Natural Products
醫學生物技術暨檢驗學系
生物資訊、老化、肥胖、細胞老化、天然物、中草藥、細胞外囊泡、皮膚老化、再生醫學、Connectivity Map、GSEA、AI、化合物-蛋白質對接分析、senescence、obesity、cellular aging、natural products、herbal drugs、extracellular vesicles、skin aging、rejuvenation medicine、bioinformatics、docking analysis
碩士1122026-01-292.50 年
114
Artificial Intelligence–Guided Peptide Design Reprograms Mesenchymal Stem Cell–Derived Extracellular Vesicle microRNA Cargo for Disease-Modifying Osteoarthritis Therapy
生物藥學研究所・共同指導:廖秀蓉
退化性關節炎、間質幹細胞、胞外體、miRNA、軟骨再生、Osteoarthritis、Mesenchymal stem cells、Extracellular vesicles、cartilage regeneration
碩士1122026-01-282.49 年
114
Pharmacokinetic and Toxicological Profiles of GLP-1 Receptor Agonists and Their Implications for Clinical Decision-Making and Business Model Innovation
生技醫療經營管理碩士在職學位學程
GLP-1受體促效劑、藥物動力學(ADME)、毒性安全性、產業競爭分析、醫療支付、風險分層支付、GLP-1 receptor agonists、pharmacokinetics (ADME)、toxicity and safety、industry competition、healthcare reimbursement、risk-stratified payment
碩士在職專班1122025-08-262.07 年
113
Investigation of the effect of an anti-cancer stemness drug on the crosstalk within the tumor microenvironment in pancreatic cancer
生物藥學研究所
胰臟導管腺癌、纖維化、胞外泌體、抗藥性、纖維連結蛋白(fibronectin)、pancreatic ductal adenocarcinoma (PDAC)、fibrosis、extracellular vesicle (EV)、drug resistance、fibronectin
碩士1122025-08-152.04 年
113
Comparative Functional Assessment and Product Development of Multi-Source Extracellular Vesicles for Applications in Skin Anti-Aging and Regeneration
生物藥學研究所・共同指導:廖秀蓉
細胞外囊泡、皮膚老化、再生醫學、植物來源 EVs、幹細胞來源 EVs、中草藥萃取物、微針貼片、Extracellular vesicles、skin aging、regenerative medicine、plant-derived EVs、stem cell–derived EVs、herbal extracts、microneedle patch
碩士1122025-08-152.04 年
113
Therapeutic Applications of Peptide-Primed Mesenchymal Stem Cell-Derived Extracellular Vesicles in Osteoarthritis Treatment
生物藥學研究所・共同指導:廖秀蓉
胜肽、間質幹細胞、細胞外囊泡、骨關節炎、軟骨分化、Osteoarthritis、peptide、chondrogenesis、mesenchymal stem cells、extracellular vesicles
碩士1122025-08-152.04 年
113
Elucidation of the mechanisms underlying an increased resistance to chemotherapy drugs in the colorectal cancer cells
生物藥學研究所
大腸直腸癌、癌幹細胞、抗藥性、GATA6、Notch1訊號路徑、Hes7、雙硫龍、脫氫表雄酮、colorectal cancer、cancer stem cell、drug resistance、Notch1 pathway、disulfiram、withaferin A、dehydroepiandrosterone
碩士1112025-08-153.04 年
113
Exosome Technology in Aesthetic and Regenerative Medicine: Global Trends, Regulatory Challenges and Commercialization Strategies
生技醫療經營管理碩士在職學位學程
外泌體、醫學美容、再生醫學、法規挑戰、商業模式、工程化外泌體、Exosomes、Aesthetic Medicine、Regenerative Therapy、Commercialization、Regulation、Engineered Exosomes
碩士在職專班1122025-08-112.03 年
113
mRNA-Loaded Extracellular Vesicles Derived from Mesenchymal Stem Cells Promote Chondrogenesis: A Precision Molecular Therapy for Osteoarthritis
生物藥學研究所・共同指導:廖秀蓉
退化性關節炎、胞外體、軟骨再生、胞奈米電穿孔、基因遞送技術、Osteoarthritis、Extracellular vesicles、Chondrogenesis、Cellular nanoporation、Gene delivery
碩士1122025-08-112.03 年
113
The application of drug repurposing strategies to develop novel treatments for non-muscle invasive bladder cancer and metastatic colorectal cancer
分子醫學博士學位學程
精準醫療、非肌肉浸潤性膀胱癌、TP53、mitomycin、大腸直腸癌、共識分子亞型、statin、precision medicine、non-muscle invasive bladder cancer、colorectal cancer、consensus molecular subtype
博士1052025-08-019.00 年
113
Research and application of innovative Chinese medicine formula to delay natural brain aging and aging-related disease in mice
生物藥學研究所・共同指導:蕭永基
阿茲海默氏症、腦部自然老化、類澱粉蛋白、脂褐質、神經元新生、DS21、Ct/Cs、Alzheimer’s disease、Brain natural aging、amyloid β protein、lipofuscin、Neurogenesis
碩士1122025-07-302.00 年
113
Business Model for the Inheritance of the Lost Tongren Manual and Ancient Medical Texts
生技醫療經營管理碩士在職學位學程
銅人簿、承繼、發展、醫術、研究價值、Tong Ren Book、Inheritance、Development、Medical skills、Research value
碩士在職專班1122025-06-171.88 年
113
Targeting Microglial Function for Alzheimer's Disease Treatment: Investigating the Effects of Erinacines and Adipose mesenchymal stem cell-Derived Exosomes
分子醫學博士學位學程・共同指導:蕭永基
阿茲海默症、erinacines、ADSC來源外泌體、小膠質細胞、抗發炎、Alzheimer's disease、ADSC-derived exosomes、microglia、anti-inflammation
博士1092025-02-074.52 年
113
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer
分子醫學博士學位學程
非小細胞肺癌、Gemcitabine、TP53、熱點突變、DNA修復、lung cancer、hotspot mutations、DNA repair
博士1062025-02-057.52 年
113
To investigate the effect of BMX and Dasatinib on glioblastoma by targeting TP53 status
醫學生物技術暨檢驗學系
膠質母細胞瘤、TP53、BMX、達沙替尼、替莫唑胺、Glioblastoma (GBM)、Dasatinib、temozolomide
碩士1112024-08-162.04 年
113
Elucidating the Molecular Mechanisms of DHEA in Colorectal Cancer Treatment
生物藥學研究所・共同指導:張牧新
結直腸癌、DHEA、Wnt/β-聯通蛋白信號通路、內質網壓力、自噬反應、細胞凋亡、癌症幹細胞、化療抗藥性、Colorectal cancer、Wnt/β-catenin、ER stress induction、autophagy activation、apoptosis induction、CSCs、chemo-drug resistance
博士1092024-02-043.51 年
112
Investigating the pro-cancer metastasis mechanism and potential therapeutic targets in non-small cell lung cancer-derived extracellular vesicles
生物藥學研究所
非小細胞肺癌、細胞外囊泡、CY001、EGFR、KRAS、整合素α6/β4、NSCLC、EV、integrin α6/β4
碩士1112024-08-212.06 年
112
A state-of-the-art ex vivo tumoroid culturing platform embracing 3Rs for precision medicine
生物藥學研究所
三維類腫瘤、胰臟癌、協同效應、癌幹細胞、化療抗性、精準醫療、3D tumoroid、Pancreatic cancer、Synergistic effect、Cancer stem cells、Chemoresistance、Precision medicine
碩士1112024-08-202.05 年
112
Exploration of the therapeutic impact of statin drugs on chemo-resistant colorectal cancer
生物藥學研究所
大腸癌、化療耐藥、Wnt/β-catenin、自噬通量、內質網壓力、細胞凋亡、Colorectal cancer、chemotherapy resistance、autophagy flux、endoplasmic reticulum stress、apoptosis
碩士1112024-08-192.05 年
112
Differential Exploration of the Therapeutic Efficacy of Thioridazine Enantiomers in the Treatment of Colorectal Cancer
生物藥學研究所
大腸癌、硫利達嗪、鏡像異構物、內質網壓力、甲羥戊酸途徑、Colorectal cancer、Thioridazine、Enantiomers、ER stress、Mevalonate pathway
碩士1112024-08-192.05 年
112
New insights into an antipsychotic drug targeting membrane proteins and lipid rafts for non-small cell lung cancer therapy
生物藥學研究所
CY001、非小細胞肺癌、抗藥性、脂筏、non-small cell lung cancer (NSCLC)、drug resistance、lipid rafts
碩士1112024-08-172.05 年
112
Investigation of Therapeutic Extracellular Vesicles for Anti-Aging
生物藥學研究所・共同指導:蕭永基
老化、細胞外囊泡、脂肪衍生幹細胞、衰老相關的β-半乳糖苷酶、尾靜脈注射、老化小鼠模型、攜帶治療性RNA之細胞外囊泡、Aging、extracellular vesicles、adipose-derived stem cells、aging-related β-galactosidase、aging mouse model、intravenous administration、engineered EVs
碩士1112024-08-162.04 年
112
Engineering Extracellular Vesicles as Novel Carriers for RNA Therapeutics in Diseases Not Amenable to Traditional Therapies
生物藥學研究所・共同指導:張牧新
基因和核酸療法、工程化胞外體、細胞奈米電穿孔、RNA載入、雙重靶向、組合療法、Gene and nucleic acid therapy、Engineered extracellular vesicles、Cellular nanoporation、RNA loading、dual-targeting、combinatorial therapy
博士1092024-08-164.04 年
112
Encapsulation of RNA Therapeutics in Engineered Extracellular Vesicles derived from Mesenchymal Stem Cells to Improve Chondrogenesis
生物藥學研究所
骨關節炎、間質幹細胞、細胞外囊泡、關節軟骨再生、Osteoarthritis、Mesenchymal stem cells、Extracellular vesicles、Cartilage regeneration
碩士1112024-08-122.03 年
112
Mesenchymal stem cells delivery system for anti PDAC oncolytic adenovirus
生物藥學研究所・共同指導:劉俊煌
delivery system、mesenchymal stem cell、adenovirus、oncolytic virus、pancreatic ductal adenocarcinoma、遞送系統、間質幹細胞、腺病毒、胰腺癌、溶瘤病毒
碩士1112024-08-092.02 年
112
Structure arrays of hinge and transmembrane domains affect anti-tumor activities of anti-CD19 CAR-T
生物藥學研究所・共同指導:劉俊煌
CD19、tEGFR、CAR-T、慢病毒、慢性髓細胞性白血病、Lentivirus、B-cell acute lymphocytic leukemia
碩士1112024-07-291.99 年
112
Utilizing genetic testing to predict the risk of renal failure for precision health management
生技醫療經營管理碩士在職學位學程
全基因組關聯分析、慢性腎臟病、多基因風險分數、Genome-wide association study、Chronic Kidney disease、Polygenetic Risk Score
碩士在職專班1112024-07-161.96 年
112
Identifying Potential Predictive Biomarkers in the Landscape of In Vitro Fertilization
生物藥學研究所
extracellular vesicles (EVs)、embryo selection、in vitro fertilization (IVF)、Infertility、細胞外囊泡、胚胎選擇、不孕症、體外受精
碩士1102024-01-292.49 年
112
Extracellular vesicles derived from mesenchymal stem cells encapsulated with specific microRNA for the modulation of chondrogenic capacity
生物藥學研究所
細胞外囊泡、微小 RNA、華通氏膠質衍生幹細胞、奈米通道電穿孔、膝蓋脂 肪墊衍生幹細胞、extracellular vesicles (EVs)、microRNAs (miRNAs)、Wharton's jelly-derived mesenchymal stem cells (WJMSCs)、nanochannel electroporation (NEP)
碩士1102024-01-272.49 年
109
Targeted Extracellular Vesicles Containing shKRASG12D Inhibit the Progression of Pancreatic Ductal Adenocarcinoma
生物藥學研究所
胰臟導管腺癌、治療型外泌體、細胞外囊泡、奈米電穿孔技術、KRAS突變、精準醫療、基因療法、Pancreatic ductal adenocarcinoma、Therapeutic exosomes、Extracellular vesicles、Nano electroporation、KRAS mutation、Precision medicine、Gene therapy
碩士1082021-09-162.13 年
109
Oroxylin A Promotes Retinal Ganglion Cells Survival in a Rat Optic Nerve Crush Model and a Rat Anterior Ischemic Optic Neuropathy Model
臨床醫學研究所
微膠細胞、非動脈炎性缺血性視神經病變、視網膜節細胞、視網膜光學斷層掃描儀、木蝴蝶素-A、創傷性視神經病變、閃光式視覺誘發電位、Microglia、Nonarteritic anterior ischemic optic neuropathy、retinal ganglion cell、optical coherence tomography、Oroxylin A、traumatic optic neuropathy、Visual evoked potential
博士972021-09-1413.12 年
109
The anti-angiogenic effect of the Astragalus-based Chinese herbal medicine on non-small cell lung cancers
生物藥學研究所
非小細胞肺癌、EGFR、抗藥性、血管新生、YQ1、NSCLC、Drug resistance、Angiogenesis
碩士1082021-08-272.07 年
109
Immunomodulatory effects of Chinese herbal regimens in human macrophages to treat non-small cell lung cancer and COVID-19-associated ARDS
生物藥學研究所
THP-1巨噬細胞、中草藥複方、氧化壓力、非小細胞肺癌、2019年新型冠狀病毒肺炎、THP-1-derived macrophage、Chinese herbal regimens、oxidative stress、non-small cell lung cancer、coronavirus disease 2019
碩士1082021-08-232.06 年
109
Investigating the anti-cancer activity of a novel curcumin analog ALZ003 in bladder cancer cells
生物藥學研究所
膀胱癌、薑黃素衍生物、粒線體、細胞凋亡、粒線體自噬、bladder cancer、curcumin analog、mitochondria、apoptosis、mitophagy
碩士1082021-08-232.06 年
109
Application of a data mining platform to identify biomarkers for patient stratification and novel mechanism of afatinib in the treatment of head and neck cancer (HNSCC)
生物藥學研究所
生物資訊分析、資料探勘、生物標誌物、妥復克膜衣錠、頭頸癌、bioinformatics、data mining、biomarkers、afatinib、head and neck cancer
碩士1082021-08-102.03 年
108
Perturbation of mitochondrial reactive oxygen species and dynamics by curcumin analog for cancerous cells constrained on adhesive protein micropatterns
生物藥學研究所・共同指導:朱業修
None、Curcumin analog (CA)、ROS measurement、Mitochondrial dynamics、Adhesive protein micropattern
碩士1072020-08-252.07 年
108
Formulation design to improve the bioavailability of poorly absorbed substance and the potential application using gene expression signature to validate its characteristics
臨床醫學研究所
None
博士992020-02-129.53 年
108
Investigation of compound D as a therapeutic application against head and neck cancer
生物藥學研究所
頭頸癌、癌症幹細胞、老藥新用、藥物組合、Head and neck cancer、Cancer stem cells、Drug repurposing、Drug combination
碩士107—無法計算
107
Characterization of Potential New Targets and Therapeutic Agents for Nasopharyngeal Carcinoma
臨床醫學研究所
鼻咽癌、硫鍊絲菌素、抗癌藥物、微陣列、Nasopharyngeal carcinoma、Thiostrepton、Podoplanin、Anticancer drug、microarray
博士972019-07-1610.95 年
107
Repurposing of cardiac glycosides as promising anti-cancer drugs for combination therapy on hepatocellular carcinoma
生物藥學研究所
肝癌、老藥新用、強心配醣體、蕾莎瓦抗藥性、Hepatocellular carcinoma、Drug repurposing、Cardiac glycosides、Sorafenib resistance
碩士106—無法計算
106
Investigating the effect of components of Antrodia camphorata on attenuating Alzheimer's disease pathology in APP/PS1 transgenic mice
生物藥學研究所・共同指導:蕭永基
阿茲海默氏症、牛樟芝、Alzheimer's disease、Antrodia camphorata
碩士1052018-08-222.06 年
106
Mechanistic investigation of curcumin analog-mediated proteostasis in prostate cancer cells
生物藥學研究所
雄腺素受體、去勢頑抗型攝護腺癌、雄性素受體變異體7、薑黃素類似物、未折疊蛋白質反應、androgen receptor、castration resistance prostate cancer、AR-V7、curcumin analog、unfolded protein response
碩士105—無法計算
105
The Study of Ovarian Cancer Subtype, Periostin in Chemo-Resistance, and Hereditary Breast and Ovarian Cancer in Taiwan
臨床醫學研究所
卵巢癌、病理分型、遺傳性乳癌卵巢癌症候群、骨膜素、鉑金抗藥性、ovarian cancer、subtype、hereditary breast-ovarian cancer、periostin、platinum resistance
博士972017-08-299.08 年
105
Characterization of anti-psychotic agents as lung cancer stem cell inhibitors
生物藥學研究所・共同指導:劉俊煌
抗精神病藥物、肺癌幹細胞、血管新生、anti-psychotic agents、lung cancer stem cell、angiogenesis
碩士1042017-08-252.07 年
105
Precision medicine-based drug development through big data and microarray analysis
醫學生物技術暨檢驗學系
精準醫療、合成致死、肺癌、大數據分析、NCI-60、YQ1、precision medicine、synthetic lethality、lung cancer、big data analysis
碩士1042017-08-252.07 年
105
Investigating the role of dopa decarboxylase in hepatocellular carcinoma
生物藥學研究所・共同指導:劉俊煌
多巴脫羧酶、肝癌、dopa decarboxylase、hepatocellular carcinoma
碩士1042017-08-232.06 年
105
The therapeutic potential of salvianolic acid F derivatives for Alzheimer ’s disease targeting on modulating microglia phenotype
生物藥學研究所・共同指導:蕭永基
阿滋海默氏症、微小膠細胞、丹參酚酸、Alzheimer ’s disease、microglia、Salvianolic acid F
碩士1042017-08-072.02 年
105
Guiding drug repurposing for precision medicine via novel big data approaches
臨床醫學研究所
大數據資料庫、藥物開發、老藥新用、微陣列、藥物註解、Big data、Database、Drug repurposing、Microarray、Drug annotation
碩士1042017-07-041.92 年
105
Investigating the Neuroprotective Activity and Mechanism of Synthetic Salvianolic acid F
生物藥學研究所・共同指導:蕭永基
丹參酚酸、阿茲海默症、藤紫丹酸B、Salvianolic acid F、alzheimer's disease、tournefolic acid B、TAB
碩士1032017-02-092.53 年
104
Investigating the therapeutic potential of Hericium erinaceus mycelium on Alzheimer's disease
生物藥學研究所・共同指導:蕭永基
阿茲海默氏症、APP/PS1基因轉殖小鼠、類澱粉乙型蛋白、猴頭菇、猴頭素A、胰島素降解酶、神經生長因子、基質金屬蛋白酶-9、神經元新生、Alzheimer’s disease、APP/PS1 transgenic mice、Amyloid β、Hericium erinaceus、Erinacine A、Insulin-degrading enzyme、Nerve growth factor、Matrix metalloproteinase-9、Neurogenesis
逕讀博士972016-08-238.06 年
104
Using synthetic lethal based approach to predict drug and biomarker pairs for personalized medicine
生物藥學研究所
None
碩士1002016-07-114.94 年
103
Investigation and development of Graptopetalum paraguayense and its active components as anti-liver fibrotic and anti-liver cancer drugs
生物藥學研究所(103)
石蓮花、肝癌、肝纖維化、B型肝炎病毒、Graptopetalun paraguayenseas、HCC、Liver fibrosis、HBV
博士982015-08-246.06 年
103
Identification of the phenothiazine-derived drug targeting the KRAS-mutant cells in non-small cell lung cancer
生物藥學研究所(103)
吩噻嗪、癌症幹細胞、非小細胞肺癌、Phenothiazine、Cancer stem cell、Non-small cell lung cancer
碩士1022015-08-242.06 年
103
Effects of the Chinese herbal medicine in combination with cisplatin on non-small-cell lung cancer
醫學生物技術暨檢驗學系
中草藥、順鉑、肺癌、Chinese herbal medicine、cisplatin、non-small-cell lung cancer
碩士1022015-08-212.05 年
103
The effects of cardiac glycosides on hepatocellular carcinoma
醫學生物技術暨檢驗學系
肝癌、強心配醣體、hepatocellular carcinoma (HCC)、cardiac glycosides
碩士1022015-08-172.04 年
103
Elucidating drug repurposing in non-small cell lung cancer via microarray-based profiling
生物藥學研究所(103)
非小細胞肺癌、止吐藥、微陣列晶片、細胞自噬、癌症幹細胞、Non-small cell lung cancer、anti-emetic drug、microarray、autophagy、cancer stem cell
碩士1022015-08-132.03 年
103
Withaferin A as a Potential Radiation Sensitizer in Non-small Cell Lung Cancer
臨床醫學研究所・共同指導:林進清
Withaferin A、非小細胞肺癌、放射治療、缺氧誘導因子、NSCLC、Radiation、HIF-1
碩士在職專班1002015-02-063.52 年
102
Investigating the effect of herbal medicine and Connectivity Map predicted drugs for treatment of Alzheimer’s disease
生物藥學研究所(103)・共同指導:蕭永基
中草藥、阿茲海默症、澱粉蛋白、herbal medicine、connectivity map、Alzheimer’s disease、Aβ
碩士1012014-08-262.07 年
102
Evaluating the inhibitory effects of prochlorperazine and thiostrepton on some stem cell properties of human lung cancer
生物藥學研究所(103)
None
碩士1012014-08-252.06 年
102
Mechanistic study of growth inhibition of lung adenocarcinoma stem cells by phenothiazine-derived compounds through identifying drug targets
生物藥學研究所(103)・共同指導:林照雄
肺癌、癌症幹細胞、富祿綠、抗精神病用藥、吩噻嗪、lung cancer、cancer stem cells、trifluoperazine、anti-psychotic agent、phenothiazine
碩士1012014-08-252.06 年
102
Mechanistic Study of Anti-hepatitis B Virus and Gluconeogenensis of Graptopetalum paraguayense in Human Hepatoma Cells
生化暨分子生物研究所・共同指導:葉小帆
石蓮花、B型肝炎病毒、糖質新生、PGC-1α、Graptopetalum paraguayense、HBV、Gluconeogenesis
碩士1012014-08-172.04 年
102
Thioridazine, an antipsychotic agent, inhibits cancer stem cell growth and induces autophagy of Glioblastoma Multiforme
生物藥學研究所(103)
細胞自嗜、抗精神疾病用藥、癌症幹細胞、膠質細胞瘤、甲硫達嗪、autophagy、antipsychotic agent、cancer stem cells、glioma、thioridazine
碩士1012014-08-122.03 年
102
Small Pool Antibody Expression Screening for the Membrane-associated-proteins as Biomarkers for Cancer Prognosis
醫學生物技術暨檢驗學系
肝癌、SPAG5、上皮細胞中胚轉化、蕾莎瓦、hepatocellular carcinoma、epithelial-mesenchymal transition、sorafenib
碩士1012014-08-122.03 年
102
Characterization of CRKL as a therapeutic target in sorafenib resistant hepatocellular carcinoma
生物藥學研究所(103)
肝癌、上皮細胞中胚轉化、蕾莎瓦、hepatocellular carcinoma、CRKL、epithelial-mesenchymal transition、sorafenib
碩士1012014-08-112.03 年
102
Systematic analyses of protein-protein interaction network for identifying new cancer therapeutic targets
臨床醫學研究所
蛋白質交互作用、訊息傳遞網絡、非小細胞肺癌、肝癌、癌症治療標的、protein-protein interaction、signaling pathway network、non-small cell lung cancer、hepatocellular carcinoma、cancer therapeutic targets
博士992014-06-203.89 年
102
Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.
生物醫學資訊研究所
肝癌、選擇性剪接、全轉錄體定序、次世代定序技術、遁去的一、生物指標、Hepatocellular Carcinoma、Alternative Splicing、RNA-Seq、Next generation sequencing technology、DUNQU1、Biomarker
博士972013-11-275.32 年
102
To investigate the regulation of Graptopetalun paraguayense in TGF-β pathway and lipogenesis in HCC via gene expression signature
生物藥學研究所(103)
肝癌、轉型生長因子β、脂質新生、Hepatocellular carcinoma (HCC)、TGF-β、lipogenesis
碩士1012013-08-251.07 年
102
Using Bioinformatics Tools to Identify New Treatment Strategy for Non Small Cell Lung Cancer
臨床醫學研究所
肺癌、生物資訊、關聯性圖譜、癌症幹細胞、吩噻嗪、乙烯膽鹼受體、lung cancer、bioinformatics、connectivity map、cancer stem cell、phenothiazine、acetylcholinergic receptor
博士982013-07-153.95 年
101
Drug Repurposing via Connectivity Map
生物藥學研究所(103)
網路連接資料庫、老藥新用、抗精神病藥、健保資料庫、文獻檢索、專利檢索、Connectivity Map、Drug Repurposing、Anti-psychotic Agent、National Health Insurance Research Database、literature review、patent survey
碩士1002013-08-262.07 年
101
Identify NPC Therapeutic Targets and Potential Drugs
臨床醫學研究所・共同指導:林進清
鼻咽癌、蛋白質蛋白質交互作用、連接網絡資料庫、支持向量機、基因、藥物、Nasopharyngeal carcinoma、Protein-protein interaction、Connectivity Map、Support Vector Machines、Gene、Drug
博士952013-08-027.00 年
101
Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma and Cholangiocarcinoma
臨床醫學研究所
關聯性圖譜、肝惡性腫瘤、膽管癌、熱休克90抑制劑、抗精神科藥物、The Connectivity Map、Hepatocellular carcinoma、Cholangiocarcinoma、HSP90 inhibitors、Anti-psychotic drugs
博士982012-01-282.49 年
100
Search for drugs with similar gene expression signature to Graptopetalum paraguayense and its purified fraction HH-F3 via Connectivity Map
醫學生物技術暨檢驗學系
肝癌、肝纖維化、藥物篩選、石蓮花、Hepatocellular carcinoma、Liver fibrosis、Drugs screening、Graptopetalum paraguayense
碩士992012-08-172.05 年
100
Identification of Thioridazine as an anti-glioblastoma agent via Connectivity map
醫學生物技術暨檢驗學系・共同指導:陳一村
甲硫達嗪、精神疾病用藥、癌症幹細胞、膠質細胞瘤、蛋白耦合性受體、細胞自嗜、thioridazine、psychotic drug、cancer stem cell、glioma、G-protein coupled receptor、autophagy
碩士992012-08-082.02 年